The assessment discusses fifty eight peptides in different clinical phases, indicating a robust pipeline of peptide therapies concentrating on PPIs. Clinical trials and preclinical studies are highlighted, displaying the efficacy of peptide vaccines in inducing an immune reaction, with the opportunity to enhance survival costs for HCC people. These studies https://anatolu123ebx0.cosmicwiki.com/user